Elsevier logo

Publisher: Elsevier

Volume 24, Number 1, January 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial board
pp. CO2+CO3-CO2+CO3(1)

Ziprasidone: An atypical antipsychotic drug for the treatment of schizophrenia
pp. 21-37(17)
Authors: Stimmel G.L.; Gutierrez M.A.; Lee V.

Bivalirudin: A direct thrombin inhibitor
pp. 38-58(21)
Author: Gladwell T.D.

A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin
pp. 112-125(14)
Authors: Davidson M.H.; Lukacsko P.; Sun J.X.; Phillips G.; Walters E.; Sterman A.; Niecestro R.; Friedhoff L.

A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL study
pp. 126-138(13)
Authors: MAPAVEL Investigators; Coca A.; Calvo C.; Garcia-Puig J.; Gil-Extremera B.; Aguilera M.T.; de la Sierra A.; Martin-Hidalgo A.; Marin R.

Our love affair with antibiotics: How will it end?
pp. 140-141(2)
Author: Coons S.J.

A retrospective analysis of costs and patterns of treatment for external genital warts in the Netherlands
pp. 183-196(14)
Authors: van der Meijden W.I.; Notowicz A.; Blog F.B.; Langley P.C.

Dear Dr. Walson:
pp. 205-207(3)
Authors: Noel F.; Berringer R.; Patel U.

The author replies:
pp. 207-208(2)
Author: Guthrie R.M.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A